Literature DB >> 18558873

Pathology and pathogenesis of fatal Bordetella pertussis infection in infants.

Christopher D Paddock1, Gary N Sanden, James D Cherry, Anthony A Gal, Claire Langston, Kathleen M Tatti, Kai-Hui Wu, Cynthia S Goldsmith, Patricia W Greer, Jeltley L Montague, Mark T Eliason, Robert C Holman, Jeannette Guarner, Wun-Ju Shieh, Sherif R Zaki.   

Abstract

BACKGROUND: Each year, Bordetella pertussis infection causes an estimated 294,000 deaths worldwide, primarily among young, nonvaccinated children. Approximately 90% of all deaths due to pertussis in the Unites States occur in young infants. These children often develop intractable pulmonary hypertension; however, the pathophysiologic mechanism responsible for this complication has not been well characterized, and there have been no detailed descriptions of the pathology of this disease since the 1940s.
METHODS: Respiratory tissue samples obtained at autopsy from 15 infants aged <or=4 months who had polymerase chain reaction- or culture-confirmed B. pertussis pneumonia were evaluated by multiple histochemical stains, immunohistochemical evaluation, and electron microscopic examination.
RESULTS: The pulmonary histopathologic examination of the samples revealed a descending infection dominated by necrotizing bronchiolitis, intra-alveolar hemorrhage, and fibrinous edema. All samples had marked leukocytosis, and most showed luminal aggregates of abundant leukocytes in small pulmonary arteries, veins, and lymphatics. A novel immunohistochemical stain for B. pertussis revealed abundant extracellular bordetellae in cilia of the trachea, bronchi, and bronchioles, as well as intracellular bacteria and antigens in alveolar macrophages and ciliated epithelium.
CONCLUSIONS: Pertussis should be suspected in any infant death associated with marked leukocytosis, bronchopneumonia, or refractory pulmonary hypertension, particularly in children aged <or=4 months. The pathologic findings identified in the respiratory tracts of these children, in addition to recognized physiologic responses of the infant lung to hypoxia, suggest that B. pertussis pneumonia triggers a cascade of events that includes acute pulmonary vasoconstriction and pertussis toxin-mediated increases in circulating leukocyte mass. These responses ultimately compromise pulmonary blood flow, exacerbate hypoxemia, and create a vicious cycle of refractory pulmonary hypertension.

Entities:  

Mesh:

Year:  2008        PMID: 18558873     DOI: 10.1086/589753

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  110 in total

1.  Delivery of Bordetella pertussis adenylate cyclase toxin to target cells via outer membrane vesicles.

Authors:  Gina M Donato; Cynthia S Goldsmith; Christopher D Paddock; Joshua C Eby; Mary C Gray; Erik L Hewlett
Journal:  FEBS Lett       Date:  2012-01-28       Impact factor: 4.124

2.  Update on pertussis and pertussis immunization.

Authors:  Jung Yun Hong
Journal:  Korean J Pediatr       Date:  2010-05-31

3.  Intracellular trafficking of Bordetella pertussis in human macrophages.

Authors:  Yanina A Lamberti; Jimena Alvarez Hayes; Maria L Perez Vidakovics; Eric T Harvill; Maria Eugenia Rodriguez
Journal:  Infect Immun       Date:  2010-01-11       Impact factor: 3.441

4.  Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection.

Authors:  Karen M Scanlon; Yael Gau; Jingsong Zhu; Ciaran Skerry; Susan M Wall; Manoocher Soleimani; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

5.  Protecting infants from pertussis.

Authors:  Meghan Gilley; Ran D Goldman
Journal:  Can Fam Physician       Date:  2014-02       Impact factor: 3.275

6.  Maternal and neonatal vaccination protects newborn baboons from pertussis infection.

Authors:  Jason M Warfel; James F Papin; Roman F Wolf; Lindsey I Zimmerman; Tod J Merkel
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

Review 7.  Toward a mechanism-based in vitro safety test for pertussis toxin.

Authors:  Stefan F C Vaessen; Martijn W P Bruysters; Rob J Vandebriel; Saertje Verkoeijen; Rogier Bos; Cyrille A M Krul; Arnoud M Akkermans
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

8.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Christopher D Paddock; Tara F Jones; Shandra R Day; James Bowden; Melinda D Poulter; Gina M Donato; Tod J Merkel; Erik L Hewlett
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

10.  Highly differentiated human airway epithelial cells: a model to study host cell-parasite interactions in pertussis.

Authors:  Claudia Guevara; Chengxian Zhang; Jennifer A Gaddy; Junaid Iqbal; Julio Guerra; David P Greenberg; Michael D Decker; Nicholas Carbonetti; Timothy D Starner; Paul B McCray; Frits R Mooi; Oscar G Gómez-Duarte
Journal:  Infect Dis (Lond)       Date:  2015-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.